Document Detail


Evaluation of imprecision for cardiac troponin assays at low-range concentrations.
MedLine Citation:
PMID:  14656904     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (MI) has recommended that an increased cardiac troponin should be defined as a measurement above the 99th percentile value of the reference group. A total imprecision (CV) at the decision limit of </=10% is recommended. However, peer-reviewed data on assay imprecision are lacking. The purpose of this study was to construct the clinically relevant imprecision profiles for each of the commercially available cardiac troponin assays. Pools of human sera containing cardiac troponin concentrations around the MI decision limit were assessed to identify the lowest concentration associated with a 10% CV. METHODS: Eight serum pools targeting different concentrations of cardiac troponin (I and T) were prepared and stored at -70 degrees C until usage. The cardiac troponin measurement protocol consisted of two replicates per specimen per run, and one run per day for 20 days, using two reagent lots and three calibrations. Manufacturers of each cardiac troponin assay directly performed the measurements. Data analysis for each assay was centralized and performed according to the NCCLS EP5-A guideline. RESULTS: The lowest concentrations (microg/L) providing a 10% CV were as follows: AxSYM, 1.22; ACS:180, 0.37; Centaur, 0.33; Immuno 1, 0.34; Access, 0.06; Vidas, 0.36; Liaison, 0.065; Dimension, 0.26; Opus, 0.90; Stratus CS, 0.10; Immulite, 0.32; Vitros ECi, 0.44; Elecsys, 0.04; AIA 21, 0.09. CONCLUSION: No cardiac troponin assay was able to achieve the 10% CV recommendation at the 99th percentile reference limit defined by the manufacturer.
Authors:
Mauro Panteghini; Franca Pagani; Kiang-Teck J Yeo; Fred S Apple; Robert H Christenson; Francesco Dati; Johannes Mair; Jan Ravkilde; Alan H B Wu;
Related Documents :
21074364 - Left ventricular torsion by two-dimensional speckle tracking echocardiography in patien...
21542704 - Cardiac resynchronization therapy for mild-to-moderate heart failure.
21404894 - Prevalence and clinical impact of left coronary dominance in patients with aortic steno...
3698304 - Isoforms of creatine kinase mm and mb in acute myocardial infarction: a clinical evalua...
21074364 - Left ventricular torsion by two-dimensional speckle tracking echocardiography in patien...
9352174 - Intracoronary irradiation for the prevention of restenosis.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2003-12-04
Journal Detail:
Title:  Clinical chemistry     Volume:  50     ISSN:  0009-9147     ISO Abbreviation:  Clin. Chem.     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-01-30     Completed Date:  2004-02-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  327-32     Citation Subset:  IM    
Affiliation:
Laboratorio Analisi Chimico Cliniche 1, Azienda Ospedaliera 'Spedali Civili', 25125 Brescia, Italy. pantegi@bshosp.osp.unibs.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Chemistry Tests / methods,  standards,  statistics & numerical data*
Humans
Myocardial Infarction / diagnosis
Reference Values
Sensitivity and Specificity
Troponin I / blood*
Troponin T / blood*
Chemical
Reg. No./Substance:
0/Troponin I; 0/Troponin T

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotop...
Next Document:  Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid ...